國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Carbonic anhydrase as drug targetthe...

Matulis, Daumantas.

Carbonic anhydrase as drug targetthermodynamics and structure of inhibitor binding /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Carbonic anhydrase as drug targetedited by Daumantas Matulis.
其他題名:	thermodynamics and structure of inhibitor binding /
其他作者:	Matulis, Daumantas.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xxvi, 353 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Carbonic anhydrase.
電子資源:	https://doi.org/10.1007/978-3-030-12780-0
ISBN:	9783030127800$q(electronic bk.)

Carbonic anhydrase as drug targetthermodynamics and structure of inhibitor binding /
Carbonic anhydrase as drug targetthermodynamics and structure of inhibitor binding /[electronic resource] :edited by Daumantas Matulis. - Cham :Springer International Publishing :2019. - xxvi, 353 p. :ill., digital ;24 cm.

Final ToC tbd. 1) Description of human carbonic anhydrases (12 catalytically active human isoforms; isoforms as drug targets, enzymatic activity, catalytic mechanism, thermodynamics of protonation of the water molecule in the active site) -- 2) Thermal stabilities of all isoform CA catalytic domains -- Thermodynamics of inhibitor binding to CAs (incl. intrinsic thermodynamics - not mentioned important subject in most CA literature) -- 3) Comparison of methods to determine inhibitor binding to CAs (ITC, FTSA, enzymatic activity assays) -- 4) Chemical synthesis of CA inhibitors -- 5) X-ray crystallographic structures of CAs and their complexes with inhibitors -- 6) Antibodies against CAs.

This book offers deep insights into the thermodynamics and molecular structures of the twelve catalytically active isoforms of human carbonic anhydrase (CA) with a particular focus on inhibitor binding for drug design. X-ray crystallographic structures in combination with enzyme kinetic testing provide information on the interaction of CAs and their inhibitors, knowledge which is crucial for rational drug design. CAs are zinc carrying enzymes that catalyse the reversible interconversion of carbon dioxide and bicarbonate and are involved in numerous cellular processes. They are therefore a common target for drugs. The suppression of CA activities through inhibitory compounds has found application for example in diuretics and in glaucoma therapy. In this book methods used to determine binding thermodynamics of inhibitory compounds (Isothermal titration calorimetry, Fluorescent thermal shift assay/differential scanning fluorimetry and others) will be compared in detail. Also types and chemical synthesis of CA inhibitors, the use of antibodies against CAs as well as inhibitor application in animals are discussed.

ISBN: 9783030127800$q(electronic bk.)

Standard No.: 10.1007/978-3-030-12780-0doiSubjects--Topical Terms:

675736
Carbonic anhydrase.

LC Class. No.: QP613.C37 / C373 2019

Dewey Class. No.: 572.7

Carbonic anhydrase as drug targetthermodynamics and structure of inhibitor binding /
LDR:02868nmm a2200337 a 4500 001 558562
003 DE-He213
005 20191016163632.0
006 m d
007 cr nn 008maaau
008 191219s2019 gw s 0 eng d
020 $a 9783030127800$q(electronic bk.)
020 $a 9783030127787$q(paper)
024 7 $a 10.1007/978-3-030-12780-0 $2 doi
035 $a 978-3-030-12780-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QP613.C37 $b C373 2019
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 572.7 $2 23
090 $a QP613.C37 $b C264 2019
245 0 0 $a Carbonic anhydrase as drug target $h [electronic resource] : $b thermodynamics and structure of inhibitor binding / $c edited by Daumantas Matulis.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xxvi, 353 p. : $b ill., digital ; $c 24 cm.
505 0 $a Final ToC tbd. 1) Description of human carbonic anhydrases (12 catalytically active human isoforms; isoforms as drug targets, enzymatic activity, catalytic mechanism, thermodynamics of protonation of the water molecule in the active site) -- 2) Thermal stabilities of all isoform CA catalytic domains -- Thermodynamics of inhibitor binding to CAs (incl. intrinsic thermodynamics - not mentioned important subject in most CA literature) -- 3) Comparison of methods to determine inhibitor binding to CAs (ITC, FTSA, enzymatic activity assays) -- 4) Chemical synthesis of CA inhibitors -- 5) X-ray crystallographic structures of CAs and their complexes with inhibitors -- 6) Antibodies against CAs.
520 $a This book offers deep insights into the thermodynamics and molecular structures of the twelve catalytically active isoforms of human carbonic anhydrase (CA) with a particular focus on inhibitor binding for drug design. X-ray crystallographic structures in combination with enzyme kinetic testing provide information on the interaction of CAs and their inhibitors, knowledge which is crucial for rational drug design. CAs are zinc carrying enzymes that catalyse the reversible interconversion of carbon dioxide and bicarbonate and are involved in numerous cellular processes. They are therefore a common target for drugs. The suppression of CA activities through inhibitory compounds has found application for example in diuretics and in glaucoma therapy. In this book methods used to determine binding thermodynamics of inhibitory compounds (Isothermal titration calorimetry, Fluorescent thermal shift assay/differential scanning fluorimetry and others) will be compared in detail. Also types and chemical synthesis of CA inhibitors, the use of antibodies against CAs as well as inhibitor application in animals are discussed.
650 0 $a Carbonic anhydrase. $3 675736
650 0 $a Drug targeting. $3 194481
650 1 4 $a Molecular Medicine. $3 273932
650 2 4 $a Medical Biochemistry. $3 274286
650 2 4 $a Protein-Ligand Interactions. $3 348845
650 2 4 $a Medicinal Chemistry. $3 275183
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
700 1 $a Matulis, Daumantas. $3 841256
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-12780-0
950 $a Biomedical and Life Sciences (Springer-11642)